KEY POINTS
- The FDA has approved two COVID-19 vaccines for use in the U.S.
- The Pfizer-BioNTech COVID-19 vaccine has a 95% efficacy rate
- Moderna’s vaccine offers 94% protection against the virus
- AstraZeneca has been approved for use in the U.K. with 60% effectivity
[The article has been updated to clarify that the COVID-19 vaccine from AstraZeneca has not yet received approval from the U.S. FDA as erroneously stated in an earlier version.]
Coronavirus vaccines are the world’s biggest hope in getting ourselves out of the deadly pandemic that has forced businesses to close, airline flights to remain on the ground, and people to hunker down in order to avoid various degrees of illness.
The U.S. Food and Drug Administration has approved two COVID-19 vaccines for use in this country: one from Moderna, another from Pfizer-BioNTech. A third vaccine, from AstraZeneca-Oxford, has been approved for use in the U.K., but not in the U.S.
For the entire article go to: www.ibtimes.com
